Welcome to ASCO Connection Discussion
The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.
1. What is the optimal specimen for molecular testing?
2. Should testing for ALK translocation be conducted?
3. What is the optimal first line therapy for ALK-translocated lung cancer?
1. Review two different screening tests for Lynch Syndrome
2. Recognize the actions needed to identify lynch syndrome
3. Explain the therapeutic importance of microsatellite instability in patients with metastatic colorectal cancer
1. What are conceivable next steps in managing this patient?
2. How does the molecular biology of mucosal melanoma vary from cutaneous melanoma?
3. What factors would guide subsequent treatment options?
1. What additional testing should the patient undergo?
2. Will the results of genetic testing help guide prognosis in this patient?
3. Will the results of genetic testing help determine what treatment would work best for the patient?
1. Describe patterns of response and progression in metastatic castration resistant prostate cancer
2. Discuss common molecular alterations in prostate cancer
3. Recognize conditions in which immunotherapy is a treatment option in prostate cancer